Dementia Clinical Trials

84 studies are recruiting for dementia in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 4

1. First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

   This is a first in human study that will assess the safety and diagnostic performance of [18F]RP-115 (fluorine-18 labeled RP115), a positron emission tomography (PET) agent. This agent has the potential to identify the early changes that occur in the brains of patients with Alzheimer's disease (AD)…

   Stage

   Phase 1

   Ages

   40 to 75

   Site

   China Basin, UCSF, San Francisco, California

   Run by

   David Wilson

   See if you can join NCT05374278 on ClinicalTrials.gov

2. Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department

   Delirium is highly prevalent and very bad for patients with dementia. Delirium is a dangerous medical condition that occurs in 6-38% of older Emergency Department patients and 70% of ICU patients. A person who develops delirium in the ED or hospital has a 12 times higher odds of being newly diagnos…

   Stage

   Not phased

   Ages

   65 and older

   Site

   The Ohio State University Wexner Medical Center, Columbus, Ohio

   Run by

   Ohio State University

   See if you can join NCT06326424 on ClinicalTrials.gov

3. NYSCF Scientific Discovery Biobank

   The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

   Stage

   Not phased

   Ages

   0 and older

   Site

   New York Stem Cell Foundation Research Institute, New York, New York

   Run by

   New York Stem Cell Foundation Research Institute

   See if you can join NCT06203106 on ClinicalTrials.gov

4. Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations

   The purpose of this study is to test a person-centered, nature-based non-pharmacological intervention for nursing home residents living with dementia who exhibit persistent vocalizations. The Environmental And Sensory Experience (EASE) involves the projection of a still nature image and the playing…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Drexel University, Philadelphia, Pennsylvania

   Run by

   Drexel University

   See if you can join NCT06568107 on ClinicalTrials.gov

5. Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

   Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per sec…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Andrey Vyshedskiy, Miami, Florida

   Run by

   Alzheimer's Light LLC

   See if you can join NCT03657745 on ClinicalTrials.gov

6. Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

   This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainmen…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Vivage/Beecan Corporation, Lakewood, Colorado

   Locations

   3 in total

   Run by

   University of Alabama, Tuscaloosa

   See if you can join NCT05820919 on ClinicalTrials.gov

7. Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

   This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the …

   Stage

   Phase 2

   Ages

   50 to 90

   Site

   Eastern Virginia Medical School, Norfolk, Virginia

   Run by

   Eastern Virginia Medical School

   See if you can join NCT04436081 on ClinicalTrials.gov

8. Phase I Human Analytics (HALO) Study

   Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clini…

   Stage

   Not phased

   Ages

   45 to 90

   Site

   Desert Medical Imaging, Indian Wells, California

   Run by

   HALO Diagnostics

   See if you can join NCT05423860 on ClinicalTrials.gov

9. DC Longitudinal Study on Aging and Specimen Bank

   The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal …

   Stage

   Not phased

   Ages

   45 and older

   Site

   Georgetown University Memory Disorders Program, Washington D.C., District of Columbia

   Run by

   Georgetown University

   See if you can join NCT03702907 on ClinicalTrials.gov